These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34970150)

  • 41. Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives.
    Bahramikia S; Yazdanparast R
    Eur J Pharmacol; 2013 May; 707(1-3):17-25. PubMed ID: 23528352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors.
    Young LM; Cao P; Raleigh DP; Ashcroft AE; Radford SE
    J Am Chem Soc; 2014 Jan; 136(2):660-70. PubMed ID: 24372466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Islet amyloid toxicity: From genesis to counteracting mechanisms.
    Marmentini C; Branco RCS; Boschero AC; Kurauti MA
    J Cell Physiol; 2022 Feb; 237(2):1119-1142. PubMed ID: 34636428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Dynamics Simulations Indicate Aromaticity as a Key Factor in the Inhibition of IAPP
    King KM; Bevan DR; Brown AM
    ACS Chem Neurosci; 2022 Jun; 13(11):1615-1626. PubMed ID: 35587203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pomegranate peel, chokeberry leaves and Ironwort extract as novel natural inhibitors of amylin aggregation and cellular toxicity in pancreatic β cells.
    Rishisree A; Mallory B; Elena K; Teodora J; Gordana Z; Katarina Š; Aleksandar J
    Biophys Chem; 2024 Jan; 304():107130. PubMed ID: 37952497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet β cells.
    Zhang S; Liu H; Chuang CL; Li X; Au M; Zhang L; Phillips AR; Scott DW; Cooper GJ
    FASEB J; 2014 Dec; 28(12):5083-96. PubMed ID: 25138158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Membrane permeabilization by Islet Amyloid Polypeptide.
    Engel MF
    Chem Phys Lipids; 2009 Jul; 160(1):1-10. PubMed ID: 19501206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Azadirachtin inhibits amyloid formation, disaggregates pre-formed fibrils and protects pancreatic β-cells from human islet amyloid polypeptide/amylin-induced cytotoxicity.
    Dubey R; Patil K; Dantu SC; Sardesai DM; Bhatia P; Malik N; Acharya JD; Sarkar S; Ghosh S; Chakrabarti R; Sharma S; Kumar A
    Biochem J; 2019 Mar; 476(5):889-907. PubMed ID: 30814273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Computational and Experimental Approaches to Design Inhibitors of Amylin Aggregation.
    Kumar AP; Lee S; Lukman S
    Curr Drug Targets; 2019; 20(16):1680-1694. PubMed ID: 31333136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition.
    Nedumpully-Govindan P; Kakinen A; Pilkington EH; Davis TP; Chun Ke P; Ding F
    Sci Rep; 2016 Jan; 6():19463. PubMed ID: 26763863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis.
    Yan LM; Tatarek-Nossol M; Velkova A; Kazantzis A; Kapurniotu A
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2046-51. PubMed ID: 16467158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention and promotion effects of apolipoprotein E4 on amylin aggregation.
    Lei P; Wu WH; Li RW; Ma JW; Yu YP; Cui W; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2008 Apr; 368(2):414-8. PubMed ID: 18243137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis of feline diabetes mellitus.
    O'Brien TD
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):213-9. PubMed ID: 12431815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models.
    Wirth F; Heitz FD; Seeger C; Combaluzier I; Breu K; Denroche HC; Thevenet J; Osto M; Arosio P; Kerr-Conte J; Verchere CB; Pattou F; Lutz TA; Donath MY; Hock C; Nitsch RM; Grimm J
    Nat Commun; 2023 Oct; 14(1):6294. PubMed ID: 37813862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting pancreatic beta cell death in type 2 diabetes by polyphenols.
    García-Aguilar A; Guillén C
    Front Endocrinol (Lausanne); 2022; 13():1052317. PubMed ID: 36465657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential beneficial role of isoflavones in type 2 diabetes mellitus.
    Duru KC; Kovaleva EG; Danilova IG; van der Bijl P; Belousova AV
    Nutr Res; 2018 Nov; 59():1-15. PubMed ID: 30442228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "A" is for amylin and amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2001 Jul; 2(4):124-39. PubMed ID: 11875249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.
    Akter R; Cao P; Noor H; Ridgway Z; Tu LH; Wang H; Wong AG; Zhang X; Abedini A; Schmidt AM; Raleigh DP
    J Diabetes Res; 2016; 2016():2798269. PubMed ID: 26649319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β.
    Ladiwala AR; Mora-Pale M; Lin JC; Bale SS; Fishman ZS; Dordick JS; Tessier PM
    Chembiochem; 2011 Jul; 12(11):1749-58. PubMed ID: 21671331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.